The Endotoxin Testing Blog
CMD blog posts is your source for guidance, regulatory insight, and practical strategies in endotoxin testing.
Whether you're working in pharma, biotech, diagnostics or medical devices, this blog is built for scientists, QA teams, and regulatory leads. Each post is authored by our team of scientific and regulatory specialists to help you make informed, compliant, and cost-effective decisions.
Why in-process endotoxin monitoring matters in biopharmaceutical manufacturing
Endotoxin contamination discovered at final quality control can put valuable material, manufacturing time and resources at risk. Testing at selected stages during production gives manufacturers an earlier opportunity to identify concerns and investigate their source.
For modern biopharmaceutical products, implementing that testing is not always straightforward. Complex sample matrices, limited sample volumes and demanding turnaround times can make routine monitoring difficult.
This article explores those challenges and explains how αBET® technology can support a more practical approach to in-process endotoxin testing.